Paul Geudens
Sales & Marketing chez Neuravi Ltd.
Profil
Paul Geudens is currently the Vice President-EMEA Sales & Marketing at Neuravi Ltd.
He previously worked as the Director-Sales & Marketing at Stentys SA from 2011 to 2012, as a Principal at Johnson & Johnson, as the Executive Vice President-Operations at Caliber Therapeutics, Inc., and as a Principal at Surpass Medical Ltd.
Postes actifs de Paul Geudens
| Sociétés | Poste | Début |
|---|---|---|
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Sales & Marketing | - |
Anciens postes connus de Paul Geudens
| Sociétés | Poste | Fin |
|---|---|---|
Surpass Medical Ltd.
 Surpass Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Stryker Corp., Surpass Medical Ltd. is an Israeli company that provides medical devices. The company is based in Tel Aviv, Israel. Surpass Medical was acquired by Stryker Corp. on November 01, 2012 for $134.99 million. | Corporate Officer/Principal | - |
Caliber Therapeutics, Inc.
 Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA. | Directeur des opérations | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| STENTYS | Sales & Marketing | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 4 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
Neuravi Ltd.
Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Health Technology |
Surpass Medical Ltd.
Surpass Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Stryker Corp., Surpass Medical Ltd. is an Israeli company that provides medical devices. The company is based in Tel Aviv, Israel. Surpass Medical was acquired by Stryker Corp. on November 01, 2012 for $134.99 million. | Electronic Technology |
Caliber Therapeutics, Inc.
Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA. | Health Technology |
